First Impression: Ansell (ANN) 1H17

Bell Potter


The Result was weaker than anticipated due to the underperformance of the Industrial, Medical, and Single Use segment; only the Sexual Wellness division reported better than anticipated result. Divisional EBIT: Industrial GBU EBIT up 11.7% to US$40.9m vs our Forecast US$49.1m; Single Use GBU down 3.8% to US$30.0m vs our Forecast US$33.9m; Medical up 0.9% to US$22.3m vs our Forecast US$28.1m; Sexual Wellness up 39% to $19.7m vs our Forecast US$16.4m. | Net operating cash flow down 1.9% to US$83.9m. | Outlook: F’17 EPS Guidance Range Maintained (US$1.00 to US$1.12)1.” “The second half is expected to see continued progress against the company's strategic goals. Organic growth should benefit from continued momentum of new product sales in Industrial, while Medical should make further progress as it emerges from the capacity constraints of last year and improves operational productivity.” | Today’s share price reaction: Down 3.2% to $21.48 (11.59 am).


1 stock mentioned

Bell Potter Securities is a leading Australian stockbroking, investment and financial advisory firm that provides a comprehensive offering of financial services to a diversified client base that includes individuals, institutions and corporations.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.